This website uses cookies to ensure you get the best experience. By continuing to browse the site, you agree to our use of cookies.

February Investment Report 2024

Oncology Biotech February Investment

Biggest Seed, Series A-E and Venture Investments within Oncology February 2024.

View the report at the bottom of this page.

February 2024 Snapshot:

Total Oncology Investments for Oncology Biotechs

152 Companies across EU and US were involved in some sort of cash movements (all indications, all cash types). From this $ 15,424,100,098.00 total true investment received in USA and EU within the Oncology sector in February 2024 across 33 different biotechs.

Some Notable True Oncology Investments

✅NextPoint Therapeutics - $42,500,000 (Series B): 2x Phase I for oncology trials

✅Athos Therapeutics - $ 35,000,000 (Series B): AI-based precision small molecules for autoimmune diseases and various cancer indications

✅Frontier Medicines - (Series C): multiple wholly owned precision programs including lead program novel inhibitor in Phase I trial

✅ Plus 30+ companies in the report.

Click here to view full report.

Subscribe and recieve exclusive bonuses, tips and resources
Last name
Thank you! You've now subscribed to our mailing list. You'll receive exclusive bonuses, tips and resources directly to your inbox.
Oops! Something went wrong while submitting the form.